Max Robotics — Global Service Robot Directory + US Certification

About

Kimio Ushijima is a leading figure in gynecologic oncology, with a career dedicated to advancing surgical treatments for cervical cancer. His primary research focuses on optimizing radical hysterectomy techniques to reduce invasiveness without compromising oncologic outcomes. Ushijima’s most impactful contribution is his leadership in the Japan Clinical Oncology Group study, JCOG1101, a landmark confirmatory trial evaluating modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumors 2 cm or less. This work directly addresses the critical need for less invasive surgical options, challenging the standard Piver class III hysterectomy. Beyond his clinical trials, Ushijima has been instrumental in fostering international collaboration, notably organizing the 2010 Asian Society of Gynecologic Oncology Workshop. This initiative, cited 33 times, helped build a cohesive academic network across Asia, enhancing communication and standardizing care in the region. With his work cited in major clinical guidelines, Ushijima’s legacy lies in his dual commitment to rigorous surgical research and to uniting the Asian gynecologic oncology community, making him a pivotal figure in shaping modern, patient-centered treatment paradigms.